COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
EPA:CRI - Euronext Paris - Matif - FR0000130692 - Common Stock - Currency: EUR
Taking everything into account, CRI scores 3 out of 10 in our fundamental rating. CRI was compared to 15 industry peers in the Industrial Conglomerates industry. CRI may be in some trouble as it scores bad on both profitability and health. CRI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
CRI had positive earnings in the past year.
CRI had a positive operating cash flow in the past year.
CRI had positive earnings in 4 of the past 5 years.
In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.72%, CRI is doing worse than 80.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.33%, CRI is doing worse than 80.00% of the companies in the same industry.
With a Return On Invested Capital value of 5.11%, CRI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for CRI is in line with the industry average of 6.57%.
The last Return On Invested Capital (5.11%) for CRI is above the 3 year average (4.65%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROIC | 5.11% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
CRI has a Profit Margin of 1.00%. This is amonst the worse of the industry: CRI underperforms 86.67% of its industry peers.
CRI's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.54%, CRI is doing worse than 73.33% of the companies in the same industry.
CRI's Operating Margin has been stable in the last couple of years.
CRI has a Gross Margin of 28.34%. This is amonst the worse of the industry: CRI underperforms 93.33% of its industry peers.
In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
The number of shares outstanding for CRI has been increased compared to 1 year ago.
The number of shares outstanding for CRI has been increased compared to 5 years ago.
Compared to 1 year ago, CRI has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.50, we must say that CRI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.50, CRI is doing worse than 73.33% of the companies in the same industry.
The Debt to FCF ratio of CRI is 14.78, which is on the high side as it means it would take CRI, 14.78 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 14.78, CRI is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.05 is on the high side and indicates that CRI has dependencies on debt financing.
CRI has a worse Debt to Equity ratio (1.05) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Altman-Z | 1.5 |
ROIC/WACC0.75
WACC6.81%
2.3 Liquidity
CRI has a Current Ratio of 1.25. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.25, CRI is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
A Quick Ratio of 0.82 indicates that CRI may have some problems paying its short term obligations.
The Quick ratio of CRI (0.82) is worse than 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1749.48% over the past year.
The earnings per share for CRI have been decreasing by -14.59% on average. This is quite bad
The Revenue has grown by 11.85% in the past year. This is quite good.
The Revenue has been growing slightly by 3.10% on average over the past years.
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
3.2 Future
Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 29.06% on average per year.
Based on estimates for the next years, CRI will show a small growth in Revenue. The Revenue will grow by 6.76% on average per year.
EPS Next Y146.66%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPS Next 5YN/A
Revenue Next Year9.12%
Revenue Next 2Y8.09%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 33.13, the valuation of CRI can be described as expensive.
Based on the Price/Earnings ratio, CRI is valued more expensive than 80.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.31, CRI is valued a bit more expensive.
The Price/Forward Earnings ratio is 9.73, which indicates a very decent valuation of CRI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 80.00% of the companies listed in the same industry.
CRI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.13 | ||
| Fwd PE | 9.73 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRI.
Based on the Price/Free Cash Flow ratio, CRI is valued a bit cheaper than 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.18 | ||
| EV/EBITDA | 7.33 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRI's earnings are expected to grow with 29.06% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y74.67%
EPS Next 3Y29.06%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.17%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.80, CRI is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.39, CRI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.17% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPA:CRI (6/13/2025, 7:00:00 PM)
10.6
-0.32 (-2.93%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners10.24%
Inst Owner ChangeN/A
Ins Owners64.27%
Ins Owner ChangeN/A
Market Cap263.52M
Analysts75.56
Price Target13.73 (29.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.17% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.58%
PT rev (3m)-3.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.13 | ||
| Fwd PE | 9.73 | ||
| P/S | 0.36 | ||
| P/FCF | 9.18 | ||
| P/OCF | 5.92 | ||
| P/B | 0.84 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.33 |
EPS(TTM)0.32
EY3.02%
EPS(NY)1.09
Fwd EY10.28%
FCF(TTM)1.15
FCFY10.89%
OCF(TTM)1.79
OCFY16.89%
SpS29.35
BVpS12.61
TBVpS-0.27
PEG (NY)0.23
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROCE | 6.99% | ||
| ROIC | 5.11% | ||
| ROICexc | 6.21% | ||
| ROICexgc | 14.36% | ||
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% | ||
| FCFM | 3.93% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexcg growth 3Y-6.3%
ROICexcg growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Debt/EBITDA | 4.24 | ||
| Cap/Depr | 52.67% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.27% | ||
| Profit Quality | 393.15% | ||
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 1.5 |
F-Score7
WACC6.81%
ROIC/WACC0.75
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
EPS Next Y146.66%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
Revenue Next Year9.12%
Revenue Next 2Y8.09%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
EBIT growth 1Y84.88%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year145.94%
EBIT Next 3Y48.76%
EBIT Next 5YN/A
FCF growth 1Y152.76%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y253.45%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%